-
Innovation Ranking
NewInnovation Ranking – SI-Bone Inc
SI-Bone Inc (SI-BONE) is a medical device company that develops, manufactures and distributes diagnosing and treating patients with SI joint disorders products and tools. The company offers medical devices for patients with low back issues, degenerative sacroiliitis, and SI joint disruptions. It develops iFuse Implant System that provides less invasive alternative to traditional SI fusion surgery and joint fixation. SI-BONE’s iFuse Implant System is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis. The company...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SI-544 in Psoriatic Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SI-544 in Psoriatic Arthritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SI-544 in Psoriatic Arthritis Drug Details: SI-544 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SI-544 in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SI-544 in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SI-544 in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: SI-544...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SI-101 in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SI-101 in Follicular Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SI-101 in Follicular Lymphoma Drug Details: SIRPant-M is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SI-101 in Sezary Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SI-101 in Sezary Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SI-101 in Sezary Syndrome Drug Details: SIRPant-M is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SI-101 in Mycosis Fungoides
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SI-101 in Mycosis Fungoides report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SI-101 in Mycosis Fungoides Drug Details: SIRPant-M is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SI-101 in Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SI-101 in Non-Hodgkin Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SI-101 in Non-Hodgkin Lymphoma Drug Details: SIRPant-M is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SI-101 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SI-101 in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SI-101 in Mantle Cell Lymphoma Drug Details: SIRPant-M is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SI-101 in Cutaneous T-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SI-101 in Cutaneous T-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SI-101 in Cutaneous T-Cell Lymphoma Drug Details: SIRPant-M is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SI-101 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SI-101 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SI-101 in Diffuse Large B-Cell Lymphoma Drug Details: SIRPant-M...